No. SN.LK. 62/08.0003 August 9, 2019 Subject : Management Discussion and Analysis Quarter 2 ending 30 June 2019 To The President The Stock Exchange of Thailand Indara Insurance Public Company Limited

No.SN.LK.62/11.0001 November 7, 2019 Subject: Management Discussion and Analysis Quarter 3 ending 30 September 2019 Attention: The President The Stock Exchange of Thailand Indara Insurance Public

% Company total revenue on 1st quarter of year 2020 increased 11.11 percent from the same period of last year. Main attributions are increasing in sale quantities from 2nd production line that reach normal

/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

005/2017 24 November 2017 Subject: Informing on the acquisition of assets of ZIGA Innovation Public Company Limited Attention: The President The Stock Exchange of Thailand Attachment: Disclosure of

resulting from increase in trade and other payables around 173.83 million baht. This was in line with the increase in sales and raw material prices. However, the Company remained the position without long

20% To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (“the Company”) would like to report the operating results of the Company and its subsidiaries for

(Translation) NEP-AC 001/2563 26 February 2020 Subject: Management Discussion and Analysis for year ended December 31, 2019 To : The President The Stock Exchange of Thailand Operating Result NEP

EKH/CS/2020/030 11 August 2020 Subject: Management Discussion and Analysis for the Second Quarter 2020 results To Directors and Manager The Stock Exchange of Thailand Ekachai Medical Care Public

and decreases at the same rate as the change in revenue. In terms of the profit of the Company for Q1–2021 changed in line with the change in revenue, when compare to Q4–2020 and Q1–2020. Compare to the